| Title : Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach - Ryan_2017_Br.J.Pharmacol_174_2209 |
| Author(s) : Ryan A , Polycarpou E , Lack NA , Evangelopoulos D , Sieg C , Halman A , Bhakta S , Eleftheriadou O , McHugh TD , Keany S , Lowe ED , Ballet R , Abuhammad A , Jacobs WR, Jr. , Ciulli A , Sim E |
| Ref : British Journal of Pharmacology , 174 :2209 , 2017 |
| Abstract : Ryan_2017_Br.J.Pharmacol_174_2209 |
| ESTHER : Ryan_2017_Br.J.Pharmacol_174_2209 |
| PubMedSearch : Ryan_2017_Br.J.Pharmacol_174_2209 |
| PubMedID: 28380256 |
| Gene_locus related to this paper: myctu-Rv3569c |
| Gene_locus related to this paper: myctu-Rv3569c |
Ryan A, Polycarpou E, Lack NA, Evangelopoulos D, Sieg C, Halman A, Bhakta S, Eleftheriadou O, McHugh TD, Keany S, Lowe ED, Ballet R, Abuhammad A, Jacobs WR, Jr., Ciulli A, Sim E (2017)
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach
British Journal of Pharmacology
174 :2209
Ryan A, Polycarpou E, Lack NA, Evangelopoulos D, Sieg C, Halman A, Bhakta S, Eleftheriadou O, McHugh TD, Keany S, Lowe ED, Ballet R, Abuhammad A, Jacobs WR, Jr., Ciulli A, Sim E (2017)
British Journal of Pharmacology
174 :2209